208 related articles for article (PubMed ID: 28538494)
21. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
22. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
23. 2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination.
Choi CI; Lee SJ; Choi JB; Kim TH; Lee JW; Kim JM; Bae S
Investig Clin Urol; 2024 Mar; 65(2):108-114. PubMed ID: 38454819
[TBL] [Abstract][Full Text] [Related]
24. On surmounting the barriers to HPV vaccination: we can do better.
Attia AC; Wolf J; Núñez AE
Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
[TBL] [Abstract][Full Text] [Related]
25. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
[TBL] [Abstract][Full Text] [Related]
26. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
[TBL] [Abstract][Full Text] [Related]
28. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.
Meites E; Szilagyi PG; Chesson HW; Unger ER; Romero JR; Markowitz LE
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(32):698-702. PubMed ID: 31415491
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus Vaccination Coverage in Children Ages 9-17 Years: United States, 2022.
Villarroel MA; Galinsky AM; Lu PJ; Pingali C
NCHS Data Brief; 2024 Feb; (495):1-8. PubMed ID: 38358336
[TBL] [Abstract][Full Text] [Related]
30. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.
Lindley MC; Jeyarajah J; Yankey D; Curtis CR; Markowitz LE; Stokley S
Hum Vaccin Immunother; 2016 Jun; 12(6):1519-27. PubMed ID: 27003108
[TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of male HPV vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
[TBL] [Abstract][Full Text] [Related]
32. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
Petrosky E; Bocchini JA; Hariri S; Chesson H; Curtis CR; Saraiya M; Unger ER; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(11):300-4. PubMed ID: 25811679
[TBL] [Abstract][Full Text] [Related]
33. Vaccination for Human Papillomavirus: Immunization Practices in the U.S. Military.
Buechel JJ
Clin J Oncol Nurs; 2018 Feb; 22(1):104-107. PubMed ID: 29350712
[TBL] [Abstract][Full Text] [Related]
34. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
35. STD-prevention counseling practices and human papillomavirus opinions among clinicians with adolescent patients--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1118-20. PubMed ID: 17060897
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013.
Ng J; Ye F; Roth L; Sobel K; Byron S; Barton M; Lindley M; Stokley S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(42):1185-9. PubMed ID: 26513219
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccine update.
Gilmer LS
Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
